Related Experiment Video
Updated: Sep 21, 2025

VisualEyes: A Modular Software System for Oculomotor Experimentation
Published on: March 25, 2011
Schizophrenia in Translation: Why the Eye?
Steven M Silverstein1,2,3,4, Joy J Choi1, Kyle M Green2
1Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.
Oculomics, or eye-based biomarkers, offer a promising avenue for schizophrenia research. These non-invasive markers can aid in diagnosis, prognosis, and understanding the systemic nature of schizophrenia.
Area of Science:
- Neuroscience
- Ophthalmology
- Psychiatry
Background:
- Schizophrenia is increasingly viewed as a systemic disease impacting neural, cardiovascular, and endocrine systems.
- Early signs of these dysregulations are present in individuals experiencing their first psychotic episode or those at high risk.
- Exploring biomarkers beyond traditional methods like genetics, blood, and brain imaging is crucial for developing accessible diagnostic tools.
Purpose of the Study:
- To investigate the potential of oculomics, or eye-based biomarkers, for schizophrenia diagnosis, phenotyping, treatment response, and prognosis.
- To highlight the utility of ocular metrics in understanding the systemic pathology of schizophrenia.
- To advocate for the integration of oculomics into schizophrenia research and clinical practice.
Main Methods:
- Reviewing existing research on ocular biomarkers in neurological and other medical conditions.
- Analyzing studies that have observed retinal neural layer thinning, volume loss, and microvascular changes in schizophrenia.
- Examining the relationship between abnormal pupil responses and corneal nerve integrity with brain function in schizophrenia patients.
Main Results:
- Retinal neural layer thinning and volume loss in schizophrenia correlate with illness progression, brain volume reduction, and cognitive deficits.
- Ocular findings such as microvascular changes, abnormal pupil responses, and corneal nerve disintegration are linked to brain structure and function in schizophrenia.
- Oculomics can provide insights into associated cardiovascular, neuroinflammatory, and metabolic conditions in early psychosis.
Conclusions:
- Oculomics presents a valuable, non-invasive approach for schizophrenia research and patient care.
- Eye-based biomarkers can offer objective measures for monitoring patients, predicting outcomes, and elucidating disease pathophysiology.
- Greater adoption of oculomics is recommended for advancing schizophrenia research and clinical management.
More Related Videos
07:36Eye Tracking During Visually Situated Language Comprehension: Flexibility and Limitations in Uncovering Visual Context Effects
Published on: November 30, 2018
07:45Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition
Published on: July 21, 2020
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Schizophrenia
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Accessory Structures of the Eye
Psychological and Sociocultural Causes of Schizophrenia
Focusing of Light in the Eye